11 June 2021 4 Min Read
US FDA clears J&J Covid-19 vaccine doses after months-long delay
After a thorough review of a troubled Emergent manufacturing facility, US regulators authorised two batches of the vaccine’s underlying drug substance made at the site
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In